Abstract
Immune complexes (IC) used as vaccines have the potential to enhance both antibody and cell-mediated immune responses over those obtained with antigen alone. However, difficulty of manufacture represents a significant hurdle to the widespread use of IC as vaccines. Recombinant IC (RIC) and their expression in plants enable manufacturing by the coordinate expression of immunoglobulin and antigen as a fusion protein. The use of a modular RIC system facilitates insertion of antigen genes and provides a broadly applicable platform that can be adapted for a wide variety of antigens.
Original language | English (US) |
---|---|
Pages (from-to) | 988-989 |
Number of pages | 2 |
Journal | Human Vaccines and Immunotherapeutics |
Volume | 12 |
Issue number | 4 |
DOIs |
|
State | Published - Apr 2 2016 |
Keywords
- antibody fusion
- immune complex
- recombinant plant
- transient expression
- vaccine
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Pharmacology